Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Sitalembic M 100mg/500mg Tablet

Prescription Icon
Prescription Required

Marketer

Alembic Pharmaceuticals Ltd

Salt Composition

Sitagliptin (100mg) + Metformin (500mg)

Overview Sitalembic M 100mg/500mg Tablet

Combiflex DM 100mg/500mg tablets combine two medications to effectively manage elevated blood glucose in individuals with type 2 diabetes. This dual action helps mitigate serious diabetic complications like renal impairment and vision loss, potentially lowering the risk of cardiovascular events. Combiflex DM 100mg/500mg may be used independently or in conjunction with other antidiabetic therapies. Optimal results are achieved when combined with a balanced diet and regular physical activity. Dosage is individualized based on your health status, glucose levels, and other medications. Taking it with food minimizes gastrointestinal discomfort. Consistent daily dosing at the same time maximizes therapeutic benefits; discontinuation should only occur under medical supervision. Adherence to the prescribed diet and exercise plan is crucial for successful diabetes management, as lifestyle significantly impacts glucose control. Commonly reported side effects include nausea, vomiting, diarrhea, stomach upset, headache, and pharyngitis. Hypoglycemia is a potential adverse effect, especially when used with insulin or sulfonylureas; appropriate recognition and management strategies are essential. This medication is not universally suitable. Prior to commencing treatment, inform your physician of any history of hepatic, renal, or cardiac disease, pancreatic issues, or excessive alcohol consumption. Pregnant or lactating women should consult their doctor before use. Potential drug interactions exist; disclose all current medications to ensure treatment safety. Alcohol consumption should be minimized due to its potential to exacerbate hypoglycemia. Your doctor will monitor renal function and blood glucose levels throughout the treatment period.

Uses of Sitalembic M 100mg/500mg Tablet

Managing type 2 diabetes

Major Benefits of Sitalembic M 100mg/500mg Tablet:

Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the Sitalembic M 100mg/500mg tablet whole; avoid chewing, crushing, or breaking it. Administer this medication with food.

Common Side effects of Sitalembic M 100mg/500mg Tablet:

  • Decreased appetite
  • Vomiting
  • Upper respiratory tract infection
  • Hypoglycemia (low blood glucose level)
  • Abdominal bloating
  • Nausea
  • Diarrhea

How to use Sitalembic M 100mg/500mg Tablet:

Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the Sitalembic M 100mg/500mg tablet whole; do not chew, crush, or divide it. Administer this medication with a meal.

How Sitalembic M 100mg/500mg Tablet works:

Sitalembic M, a 100mg/500mg tablet, combines sitagliptin and metformin to manage blood glucose. Sitagliptin enhances insulin production by the pancreas, improves insulin utilization, and decreases hepatic glucose output. Metformin, a biguanide, reduces liver glucose production, slows intestinal glucose absorption, and boosts insulin sensitivity. This dual action leads to improved glycemic control.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Concurrent use of alcohol and Sitalembic M 100mg/500mg tablets is inadvisable.

PregnancyPregnancyCONSULT YOUR DOCTOR

The use of Sitalembic M 100mg/500mg tablets during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to a developing fetus. A physician will assess the potential advantages against any possible hazards prior to prescribing. Seek medical advice.

Breast feedingBreast feedingCONSULT YOUR DOCTOR

Breastfeeding mothers should likely avoid Sitalembic M 100mg/500mg tablets. Available evidence from human studies indicates potential transfer of the medication into breast milk, posing a risk to the infant.

DrivingDrivingCAUTION

Driving ability can be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if you experience these blood sugar imbalances.

KidneyKidneyCAUTION

Patients with kidney impairment should use Sitalembic M 100mg/500mg tablets cautiously, potentially requiring dosage modification. Consult your physician for guidance. Sitalembic M 100mg/500mg tablets are contraindicated in individuals with severe kidney disease. Regular monitoring of kidney function is recommended during treatment.

LiverLiverUNSAFE

The use of Sitalembic M 100mg/500mg tablets is likely inadvisable for individuals with hepatic impairment and should be avoided. Medical advice is recommended.

What if you forget to take Sitalembic M 100mg/500mg Tablet :

Should you forget to take your Sitalembic M 100mg/500mg Tablet, administer it immediately upon remembering. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.

Facts to Know About Sitalembic M 100mg/500mg Tablet

LabelValue
Addictive None.
Medication Classification Medication for diabetes

FAQs on Sitalembic M 100mg/500mg Tablet

Sitalembic M 100mg/500mg tablets contain sitagliptin and metformin, working synergistically to manage type 2 diabetes in adults. This medication enhances blood sugar control when combined with a healthy diet and regular physical activity. Metformin reduces hepatic glucose production and boosts insulin sensitivity, while sitagliptin blocks DPP-4, thereby stimulating pancreatic insulin secretion. This formulation is unsuitable for individuals under 18.
Prolonged Sitalembic M 100mg/500mg Tablet use can lead to Vitamin B12 deficiency. This medication impairs Vitamin B12 absorption in the gastrointestinal tract. Consequently, untreated deficiency may result in anemia and neurological complications, manifesting as paresthesia in the extremities, generalized weakness, urinary dysfunction, cognitive changes, and gait instability. To mitigate these risks, supplemental Vitamin B12 is recommended annually by some experts.
Sitalembic M 100mg/500mg tablets may cause common side effects including low blood sugar (hypoglycemia), taste changes, nausea, abdominal pain, diarrhea, headache, and upper respiratory infections. Rare but serious side effects such as lactic acidosis are also possible. Prolonged use may result in vitamin B12 deficiency.
Patients with hypersensitivity to any Sitalembic M 100mg/500mg Tablet constituent or inactive ingredient should not use this medication. Its use is contraindicated in individuals with severe renal or hepatic dysfunction, congestive cardiac failure, lactic acidosis, or diabetic ketoacidosis.
Combining Sitalembic M 100mg/500mg Tablet with alcohol is unsafe due to a heightened risk of lactic acidosis.
Retain this medication within its original, sealed container or packaging. Follow the storage guidelines specified on the label or packaging. Discard any remaining medicine. Prevent access by children, pets, and other individuals.
Sitalembic M 100mg/500mg Tablet use may result in lactic acidosis, a serious medical condition characterized by excessive blood lactic acid. Also termed Metformin-associated lactic acidosis (MALA), this rare adverse reaction necessitates caution in patients with kidney impairment, advanced age, or significant alcohol consumption. Symptoms can manifest as muscle aches or weakness, vertigo, fatigue, cold extremities, respiratory distress, nausea, emesis, abdominal discomfort, or bradycardia. Should these symptoms appear, discontinue Sitagliptin + Metformin and seek immediate medical attention.
Sitalembic M 100mg/500mg tablets contain sitagliptin and metformin, working together to manage type 2 diabetes in adults. This medication helps regulate blood sugar levels when used with a healthy diet and regular physical activity. Metformin reduces glucose production by the liver and enhances insulin sensitivity. Sitagliptin blocks the DPP4 enzyme, thereby promoting greater insulin secretion from the pancreas. This formulation is unsuitable for individuals under 18.
Sitalembic M 100mg/500mg tablets may cause common adverse reactions including low blood glucose, taste changes, nausea, abdominal discomfort, diarrhea, headache, and upper respiratory infections. Rare but potentially serious side effects such as lactic acidosis may occur. Prolonged use can result in vitamin B12 deficiency.
Patients with hypersensitivity to any Sitalembic M 100mg/500mg Tablet ingredient or inactive component should not use this medication. Similarly, its use is contraindicated in individuals with severe renal or hepatic dysfunction, congestive heart failure, lactic acidosis, or diabetic ketoacidosis.
Combining Sitalembic M 100mg/500mg Tablet with alcohol is unsafe due to a heightened risk of lactic acidosis.
Indeed, Sitalembic M 100mg/500mg Tablet use may result in lactic acidosis, a serious medical condition characterized by excessive blood lactic acid. Also termed Metformin-associated lactic acidosis (MALA), this rare complication is linked to metformin and thus contraindicated in individuals with pre-existing kidney impairment, advanced age, or significant alcohol consumption. Lactic acidosis symptoms can manifest as muscle aches or weakness, lightheadedness, fatigue, cold extremities, shortness of breath, queasiness, vomiting, abdominal discomfort, or bradycardia. Should these symptoms arise, discontinue Sitagliptin + Metformin and seek immediate medical attention.
Prolonged use of Sitalembic M 100mg/500mg tablets can lead to Vitamin B12 deficiency. This medication impairs the stomach's absorption of Vitamin B12. Consequently, untreated deficiency may result in anemia, neurological complications including paresthesia in the extremities, generalized weakness, urinary dysfunction, cognitive changes, and ataxia. To mitigate these risks, supplemental Vitamin B12 is recommended annually by some experts.
Store this medication in its original, tightly sealed container or packaging, following all storage instructions provided on the label. Discard any leftover medication and ensure it remains inaccessible to children, pets, and other individuals.
Sitalembic M 100mg/500mg tablets contain sitagliptin and metformin, working together to manage type 2 diabetes in adults. This medication helps regulate blood sugar when combined with a healthy diet and exercise. Metformin reduces liver glucose production and enhances insulin sensitivity. Sitagliptin blocks DPP-4, boosting pancreatic insulin secretion. This formulation is unsuitable for individuals under 18.
Sitalembic M 100mg/500mg tablets may cause common adverse reactions including low blood sugar, taste disturbances, nausea, abdominal pain, diarrhea, headache, and upper respiratory infections. Rare but serious side effects such as lactic acidosis are also possible. Prolonged use might result in vitamin B12 deficiency.
Patients with hypersensitivity to any Sitalembic M 100mg/500mg Tablet ingredient or inactive component should not take this medication. Its use is contraindicated in individuals with severe renal or hepatic dysfunction, congestive heart failure, lactic acidosis, or diabetic ketoacidosis.
Combining Sitalembic M 100mg/500mg Tablet with alcohol is unsafe due to a heightened risk of lactic acidosis.
Sitalembic M 100mg/500mg Tablets can cause lactic acidosis, a serious medical condition characterized by excessive blood lactic acid. Also termed Metformin-associated lactic acidosis (MALA), this rare adverse effect necessitates caution in patients with kidney impairment, advanced age, or significant alcohol consumption. Symptoms might present as muscle aches or weakness, vertigo, fatigue, cold extremities, dyspnea, nausea, emesis, abdominal discomfort, or bradycardia. Should these symptoms occur, discontinue Sitagliptin + Metformin and seek immediate medical attention.
Prolonged use of Sitalembic M 100mg/500mg tablets can lead to Vitamin B12 deficiency by hindering its gastrointestinal absorption. This deficiency, if left unaddressed, may result in anemia and neurological complications, manifesting as paresthesia in the extremities, generalized weakness, urinary dysfunction, cognitive changes, and ataxia. Preventive strategies proposed by some researchers include annual supplementation with exogenous Vitamin B12.
Store the medication in its original, tightly sealed container, following all storage guidelines printed on the packaging. Discard any leftover medication; ensure it remains inaccessible to children, pets, and others.
Sitalembic M 100mg/500mg ...
168
MRP 195
13% off